Clinical trials
Phase 1 Triple Negative Breast Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ministry of Health, Saudi Arabia | 2 |
| Adlai Nortye Biopharma Co., Ltd. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Chinese PLA General Hospital | 1 |
| CytoMed Therapeutics Pte Ltd | 1 |
| Dr. Ronnie Shapira | 1 |
| Eileen Connolly | 1 |
| Fudan University | 1 |
| Infinity Pharmaceuticals, Inc. | 1 |
| Istituti Ospitalieri di Cremona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Melanoma | 2 |
| Mesothelioma, Malignant | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.